We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Ausam Battles Keryx Over Share Losses

Law360 (August 3, 2006, 12:00 AM EDT) -- Biopharmaceutical company Ausam Biotechnologies Inc. went head to head with Keryx Biopharmaceuticals Inc. in a federal bankruptcy court this week in a bid to force Keryx to shell out more than half a million dollars for shares it says it never received.

Ausam, which filed for Chapter 11 protection in early February, has ceased operations but continues to market its anti-viral program, one of the company’s two product lines. The anti-viral program has yet to be sold, but Ausam has said it has plans to do...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.